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ABSTRACT
Objectives: The aim of this study is to estimate the level of creatine kinase-myocardial band (CK-MB), C-reactive protein (CRP), and lactate 
dehydrogenase (LDH) biomarker in myocardial infarction (MI) (troponin T-positive) and compare with normal healthy individuals (Troponin-T [TnT] 
negative).
Methods: A cross-sectional study on 172 patients involving 100 patients with nondiabetic MI and 72 apparently healthy controls with no history 
of diabetes and/or MI was done from December 2017 to May 2018. The diagnosis of MI was established with electrocardiogram findings and TnT 
estimation. Blood samples were gathered and processed for the estimation of CK-MB, LDH, and CRP.
Results: The mean age of the cases was 62.15±7.75 years and in the controls was 61.49±8.35 years (p=0.592). The mean value of CK-MB, LDH, 
and CRP in the TnT positive group was 111.94±29.59 IU/L, 564.43±110.99 IU/L, and 15.69±4.04 mg/L, whereas in the TnT negative group was 
16.36±3.77 IU/L, 223.68±36.23 IU/L, and 6.08±2.02 mg/L, respectively (p<0.0001). CK-MB was deranged in 100% of TnT positive group, and in only 
2.78% in TnT negative group (p<0.0001). LDH was deranged in 100% TnT positive group, and in 16.67% in TnT negative group (p<0.0001). CRP was 
deranged in 4% TnT positive group, and in 0% in TnT negative group (p=0.141).
Conclusion: This study indicated that CK-MB and LDH are sensitive cardiac markers for the diagnosis of MI.
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INTRODUCTION
Myocardial infarction (MI) may be described as the death of the heart 
muscles. Coronary artery disease (CAD) leads to blood flow obstruction 
to the heart, and the results form a spectrum of diseases, acute coronary 
syndrome and a consequence of which leads to decrease in the blood 
flow to the heart [1].
CAD is one of the main causes of death and disability in developed 
countries [2]. Although the mortality for this condition has gradually 
declined over the past decades in western countries, it still causes about 
one-third of all deaths in people older than 35 years [3]. The diagnosis 
of acute MI (AMI) established by the World Health Organization, 
requires at least two of the following criteria: A history of chest pain, 
evolutionary changes on the electrocardiogram (ECG), and elevation of 
serial cardiac enzymes. If ECG fails to demonstrate an AMI, the cardiac 
markers must be used [4].
Various cardiac markers-creatine kinase (CK); lactate dehydrogenase 
(LDH); Cardiac Troponin-I and Troponin-T (TnT); myoglobin; 
cholesterol; triglycerides; low-density lipoprotein; high-density 
lipoprotein, C-reactive protein (CRP), and aspartate aminotransferase 
(AST) have been proposed till date [4]. The assessment of the 
myocardial injury varies dramatically with the detection of AST, LDH, 
creatine kinase (CK), CK isoenzymes (CKMB), and troponin (T) which 
add prognostic information regarding acute short-term or chronic long-
term risk and the severity of the injury [5].
Each individual marker carries significance in different scenarios. 
Serum LDH is a known pathologic marker for myocardial ischemia [6], 
but it can be falsely elevated with strenuous physical activity. CK-MB 
rises in the serum at 4-9 h after the onset of chest pain, peaks at 24 h 
and returns to baseline values at 48–72 h. CK-MB has an advantage 
over troponins because of the early clearance that helps to detect 
reinfarction [7]. Anoop CRP is an acute phase protein that rises with 
an inflammatory stimulus. CRP is increased in patients with unstable 
angina; however, owing to the lack of sensitivity and specificity, it 
cannot be employed as a diagnostic marker alone. As a prognostic 
indicator, high CRP levels have also been linked to poor outcome [8].
Thus, this study was conducted to assess the most sensitive cardiac 
marker out of all these three cardiac markers for the early diagnosis 
of AMI.
MATERIALS AND METHODS
A cross-sectional study was conducted in the department of biochemistry 
in a tertiary care hospital. A total of 172 patients were included in 
this study, divided into two groups. Group I (Cases) - consisted of 100 
diagnosed cases of nondiabetic MI admitted to emergency and intensive 
care units of the Santosh Medical college Hospital and RC Ghaziabad. 
Group II (controls) consisted of 72 healthy controls with no history 
of diabetes and/or MI. Informed consent was obtained from patients. 
Information extraction forms were utilized to collect data from patient 
files.
All patients >35 years (males and females) of confirmed nondiabetic 
MI based on ECG findings and cardiac enzymes (TnT/CPK-MB) were 
included in the study. Patients with diabetes mellitus having MI, 
recent history of surgery and trauma within the preceding 2 months, 
renal insufficiency (serum creatinine >1.5 mg/dl), patients with 
cerebrovascular accidents or previous history of cerebrovascular 
accidents, patients having evidence of infections, inflammatory disease, 
malignancy, patient taking drugs such as Vitamin B-complex or folic 
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acid, hormone replacement therapy, and those who were not willing 
to participate were excluded from the study. The initial evaluation 
of patients with MI consisted of history, physical examination, ECG 
changes, and laboratory investigation (Troponin T). The blood samples 
were collected from all the cases and controls and were immediately 
analyzed for biochemical parameters.
Under all aseptic precautions, about 5 ml of venous blood samples 
were collected by clean venepuncture in a sterile plain and 
ethylenediaminetetraacetic acid vial. Blood samples were allowed to 
coagulate after which they were centrifuged at 3000 rpm for 5 min to 
obtain serum. The separated clear serum was transferred into sterile 
bottles and used for the enzyme assay. When not used immediately, 
they were kept at −20°C and later used within 5 days.
Measurement of Troponin T was done qualitatively by rapid test 
kit method manufacturing by Roche Diagnostics International 
Ltd., CH-6343 Rotkreuz, Switzerland. Measurement of creatine 
kinase-myocardial band (CK-MB) and LDH was done following a 
method that has been carried out in accordance with the International 
Federation of Clinical Chemistry (IFCC) protocol. The commercial kit 
produced by TransAsia Biomedical Ltd., (H.P.) was used. Measurement 
of CRP was done by endpoint method. The commercial kit produced by 
Erba Lachema s.r.o., was used.
Statistical analysis
Categorical variables were presented in number and percentage (%), 
and continuous variables were presented as mean ± standard deviation 
and median. Normality of data was tested by the Kolmogorov–Smirnov 
test. If normality was rejected, then the nonparametric test was used.
Statistical tests were applied as follows:
1. Quantitative variables were compared using the independent 
t-test/Mann–Whitney test (when the data sets were not normally 
distributed) between the two groups
2. Qualitative variables were correlated using the Chi-Square test/
Fisher’s exact test
3. Spearman rank correlation coefficient was used to measure the 
association of various parameters with each other
4. Univariate logistic regression was used to evaluate significant risk 
factors for Troponin T positive.
A value of p<0.05 was considered as statistically significant.
Data were entered into MS Excel spreadsheet and analysis was 
performed using the Statistical Package for Social Sciences version 21.0.
RESULTS
In the present study, a total of 100 Troponin T positive cases and 72 
Troponin T negative as controls were examined. Troponin T positive 
group had 39% of patients within the age group of 61-70, 36% between 
51 and 60, 18% were >70 years, and 7% were ≤50 years. In Troponin T 
negative group, 40.28% were between 61 and 70 years, 33.33% were 
between 51 and 60 years, 16.67% were >70 years of age, and 9.72% 
were ≤50 years (Table 1 and Fig. 1). The mean age in the cases were 
62.15±7.75 years and in the controls was 61.49±8.35 years. There was 
not any statistical difference between the two groups (p=0.592). It has 
been shown in Table 1a.
In the present study, Troponin T positive group had 29% of females and 
71% of males, whereas the control group had 29.17% of females and 
70.83% of males. It has been shown in Table 2 and Fig. 2.
The mean value of CK-MB, LDH, and CRP in the Troponin T positive group 
was 111.94±29.59 IU/L, 564.43±110.99 IU/L and 15.69±4.04 mg/L, 
whereas in the Troponin T negative group it was 16.36±3.77 IU/L, 
223.68±36.23 IU/L, and 6.08±2.02 mg/L, respectively (p<0.0001) 
(Table 3).
In the present study, CK MB was deranged in 100% Troponin T positive 
group, and in only 2.78% in Troponin T negative group. The difference 
was statistically significant (p<0.0001) as shown in Table 4.
LDH was deranged in 100% Troponin T positive group, and in only 
16.67% in Troponin T negative group. The difference was statistically 
significant (p<0.0001) as shown in Table 5.
CRP was deranged in only 4% Troponin T positive group, and in 0% 
in Troponin T negative group. It was normal in the rest of the patients. 
The difference was not statistically significant (p=0.141) as shown in 
Table 6.
DISCUSSION
The ongoing battle to reduce the incidence of cardiovascular disease 
has led to the discovery of numerous clinical markers. In this study, TnT 
was taken as a standard positive marker for AMI and all correlations of 
the cardiac biomarkers were done on the basis of the groups defined 
Table 1: Age distribution
Age group (years) Troponin‑T negative (n=72), n (%) Troponin‑T positive (n=100), n (%) Total, n (%) p
≤50 7 (9.72) 7 (7.00) 14 (8.14) 0.913
51–60 24 (33.33) 36 (36.00) 60 (34.88)
61–70 29 (40.28) 39 (39.00) 68 (39.53)
>70 12 (16.67) 18 (18.00) 30 (17.44)
Fig. 1: Age distribution
Fig. 2: Gender distribution
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as Troponin T positive (cases) and TnT negative (controls). It has 
been shown that TnT serves as one of the most sensitive markers of 
myocardial injury. In Shah and Haridas study, it was seen that cardiac 
TnT was twenty times higher among patients than normal controls [9].
Although both cardiac and skeletal muscles contain TnT like other 
cardiac markers, the amino acid sequence of the protein in the two 
types of muscles differs, thus making it possible to raise antisera against 
cardiac-specific TnT and detect it more efficiently. The high specificity 
and sensitivity of cardiac TnT in diagnosing and monitoring AMI, the 
undetectable values of cardiac troponin T in healthy individuals, has 
made its measurement a powerful tool in the diagnosis of AMI [9].
In this study, the mean age of the cases was 62.15±7.75 years and the 
controls was 61.49±8.35 years. There was no statistically significant 
difference between the ages of the two groups (p>0.05). TnT positive 
group had 29% of females and 71% of males and the control group 
had 29.17% of females and 70.83% of males, which was comparable 
(p>0.05). In a comparable study, the mean age was 56.3±13.2 years, 
145 (72.5%) were male and 55 (27.5%) female [10]. In a study by 
Sorathia et al., the mean age of the 30 cases was 48.5±10.3 years and 
the 20 controls were 44.5±12.8 years which was comparable [11]. In 
another study by Singh and Manda, in 80 STEMI patients, mean age was 
53.5±1.34 years and gender distribution were 81.25% of males and 
18.75% of females [12].
Among the various cardiac markers studied, CK-MB is one of the 
most important myocardial markers, and it is an established marker 
in confirmation of AMI. In AMI, the plasma concentration of CK-MB 
increases within 4–9 h of onset of chest pain, the peak is attained within 
9–30 h and return to baseline levels after 48–72 h [7].
In the present study, the mean value of CK-MB in the Troponin T positive 
group was 111.94±29.59 IU/l and the Troponin T negative group was 
16.36±3.77 IU/l. The difference was statistically significant (p<0.0001) 
CK-MB was deranged in 100% TnT positive group, and in only 2.78% 
in TnT negative group. The difference was statistically significant 
(p<0.0001). Shah and Haridas [9] showed that CK-MB values were 
better than CK as the mean values of CK-MB after 6 h of chest pain was 
98.8±72.7 and was 8.5±14.9 among controls in TnT negative patients 
which corroborated with the present study. Aseri et al. [13] showed 
a significant difference between CK-MB values of STEMI and NSTEMI 
patients (p=0.034), thereby confirming the relevance of CK-MB as a 
cardiac marker. Shah [14] also assessed various cardiac markers in 50 
AMI cases and 20 controls. Mean values of Total CPK were 148±279.1 in 
control and 648±806.7 in MI cases. CPK-MB was 20.9 ±9.58 in control 
and 89.4±118.07 in MI cases. The difference was statistically significant 
(p=0.002), and it was comparable to our study.
Serum LDH is a known pathologic marker for a diversity of diseases, 
including myocardial ischemia. Its activity rises in serum within 
12–24 h after AMI, reaches to peak level after 48-72 h after AMI and reverts 
to normal in 10–14 days. That’s why considered as a late marker [6].
In the present study, LDH was deranged in 100% TnT positive 
group, and in only 16.67% in TnT negative group. The difference 
was statistically significant (p<0.0001). The mean value of LDH in 
the Troponin T positive group was 564.43±110.99 and the Troponin 
T negative group was 223.68±36.23. The difference was statistically 
significant (p<0.0001). Shah [14] results were slightly higher than 
ours for LDH values. The mean value of LDH was 510±199.4 in control 
and 836.6±553.1 in MI cases (p=0.002). Aseri et al. [13] showed a 
significant difference between the LDH values of STEMI and NSTEMI 
patients. (p=0.047), thereby confirming the relevance of LDH as a 
cardiac marker.
Inflammation plays a major role in the pathogenesis of atherosclerosis. 
The chronic inflammatory process develops to an acute clinical event 
by the induction of plaque rupture and therefore, causes acute coronary 
syndromes [13].
In the present study, the mean values of CRP in the Troponin T positive 
group were 15.69±4.04 and the Troponin T negative group was 
6.08±2.02. The difference was statistically significant (p<0.0001). Aseri 
et al. [13] showed a significant difference between hsCRP values of 
STEMI and NSTEMI patients. (p=0.023) This observational study reports 
that the inflammatory markers measurement in ACS, before the tissue 
necrosis, is significantly related to classical cardiac enzyme markers 
and may be of prognostic significance. CRP has been investigated 
mostly in acute coronary syndromes as a marker of proinflammatory 
state and plaque instability. Few studies also concluded that there was 
no significant correlation between hs-CRP levels and Gensini score 
index and no relationship between hs-CRP levels and the presence and 
severity of CAD in patients with stable angina [13]. All the three cardiac 
markers showed a significant association with AMI and thus shall form 
an important component of the test panel for early diagnosis of MI. The 
values should be interpreted carefully and individually as each of them 
holds a separate significance.
The study results should be interpreted within the context of several 
limitations. First, the study design prevents inference of causal 
relationships among variables. Although there has been a lot of 
research on these markers, their relevance and application to different 
geography and ethnicity remain doubtful. Finally, study on ejection 
fraction was not done on this study which forms a major component in 
the assessment of AMI.
Table 1a: Mean of age distribution
Age Troponin‑T negative (n=72) Troponin‑T positive (n=100) p
Mean±SD 61.49±8.35 62.15±7.75 0.592
Median (range) 61.5 (39–76) 62 (42–76)
IQR 56–68 56.500–68
IQR: Inter quartile range, SD: Standard deviation
Table 2: Gender distribution
Gender distribution Troponin‑T negative (n=72), n (%) Troponin‑T positive (n=100), n (%) Total, n (%) p
Female 21 (29.17) 29 (29.00) 50 (29.07) 0.981
Male 51 (70.83) 71 (71.00) 122 (70.93)








CK MB (IU/l) 16.36±3.77 111.94±29.59 <0.0001
LDH (IU/l) 223.68±36.23 564.43±110.99
CRP (mg/l) 6.08±2.02 15.69±4.04
LDH: Lactate dehydrogenase, CRP: C-reactive protein, CK MB: Creatine kinase 
muscle-brain
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CONCLUSION
CK-MB and LDH are found to be sensitive cardiac markers for the 
diagnosis of MI and thus, a panel of markers can be used for the specific 
diagnosis and follow-up of AMI cases.
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